Home > Boards > US Listed > Biotechs > Pfizer, Inc. (PFE)
Followed By 361
Posts 42975
Boards Moderated 11
Alias Born 07/20/2003

Monday, May 02, 2022 11:38:23 AM

Re: Vexari post# 4683

Post# of 4976
Peer Reviewed Study

Vaccinated to develop heart inflammation requiring hospitalization

Up to 15x more likely than unvaxxed

By Julian Conradson
Published April 25, 2022 at 4:14pm


A new study out of Europe has revealed that cases of heart inflammation that required hospitalization were much more common among vaccinated individuals compared to the unvaccinated.

A team of researchers from health agencies in Finland, Denmark, Sweden, and Norway found that rates of myocarditis and pericarditis, two forms of potentially life-threatening heart inflammation, were higher in those who had received one or two doses of either mRNA-based vaccine – Pfizer’s or Moderna’s.

In all, researchers studied a total of 23.1 million records on individuals aged 12 or older between December 2020 and October 2021. In addition to the increased rate overall, the massive study confirmed the chances of developing the heart condition increased with a second dose, which mirrors other data that has been uncovered in recent months.

From the *peer-reviewed study, which was published by the Journal of the American Medical Association (JAMA):

“Results of this large cohort study indicated that both first and second doses of mRNA vaccines were associated with increased risk of myocarditis and pericarditis. For individuals receiving 2 doses of the same vaccine, risk of myocarditis was highest among young males (aged 16-24 years) after the second dose. These findings are compatible with between 4 and 7 excess events in 28 days per 100?000 vaccinees after BNT162b2, and between 9 and 28 excess events per 100?000 vaccinees after mRNA-1273.

The risks of myocarditis and pericarditis were highest within the first 7 days of being vaccinated, were increased for all combinations of mRNA vaccines, and were more pronounced after the second dose.”


Also mirroring other data, the study confirmed that young people, especially young males, are the ones who are suffering the worst effects of the experimental jab. Young men, aged 16-24 were an astounding 5-15X more likely to be hospitalized with heart inflammation than their unvaccinated peers.

But it isn’t just young men, all age groups across both sexes – except for men over 40 and girls aged 12-15 – experienced a higher rate of heart inflammation post-vaccination when compared to the unvaxxed.

From The Epoch Times, who spoke with one of the study’s main researchers, Dr. Rickard Ljung:

“‘These extra cases among men aged 16–24 correspond to a 5 times increased risk after Comirnaty and 15 times increased risk after Spikevax compared to unvaccinated,’ Dr. Rickard Ljung, a professor and physician at the Swedish Medical Products Agency and one of the principal investigators of the study, told The Epoch Times in an email.

Comirnaty is the brand name for Pfizer’s vaccine while Spikevax is the brand name for Moderna’s jab.

Rates were also higher among the age group for those who received any dose of the Pfizer or Moderna vaccines, both of which utilize mRNA technology. And rates were elevated among vaccinated males of all ages after the first or second dose, except for the first dose of Moderna’s shot for those 40 or older, and females 12- to 15-years-old.”


Although the peer-reviewed study found a direct link between mRNA based vaccines and increased incident rate of heart inflammation, the researchers claimed that the “benefits” of the experimental vaccines still “outweigh the risks of side effects,” because cases of heart inflammation are “very rare,” in a press conference about their findings earlier this month.

However, while overall case numbers may be low in comparison to the raw numbers and thus technically “very rare,” the rate at which individuals are developing this serious condition has increased by a whopping amount. When considering the fact that 5-15X more, otherwise healthy, young men will come down with the condition – especially since the chances of Covid-19 killing them at that age are effectively zero (99.995% recovery rate) – it’s downright criminal for governments across the world to continue pushing mass vaccinations for everyone.

Dr. Peter McCullough, a world-renowned Cardiologist who has been warning about the long-term horror show that is vaccine-induced myocarditis in young people, certainly thinks so. In his expert opinion, the study does anything but give confidence that the benefits of the vaccine outweigh the risks. In “no way” is that the case, he says. Actually, it’s quite the opposite.

From McCullough, via The Epoch Times:

“In cardiology we spend our entire career trying to save every bit of heart muscle. We put in stents, we do heart catheterization, we do stress tests, we do CT angiograms. The whole game of cardiology is to preserve heart muscle. Under no circumstances would we accept a vaccine that causes even one person to stay sustain heart damage. Not one. And this idea that ‘oh, we’re going to ask a large number of people to sustain heart damage for some other theoretical benefit for a viral infection,’ which for most is less than a common cold, is untenable. The benefits of the vaccines in no way outweigh the risks.”

It’s also worth pointing out that the new study’s findings could be an indicator as to what is driving the massive spike in the excess death rates in the United States and across the world. Correlating exactly with the rollout of the experimental mRNA Covid-19 vaccines, people have been dying at record-breaking rates, especially millennials, who experienced a jaw-dropping 84% increase in excess deaths (compared to pre-pandemic) in the final four months of 2021.

With all the data that has been made available up to this point, there is no denying that the vaccine is at least partially to blame for the spike in severe illness and death, if not entirely. Nevertheless, the CDC, Fauci, Biden, and the rest of the corrupt establishment continue to push mass vaccines, just approved another booster jab (with plans for another already in the works), and are licking their chops to unleash another round of Covid hysteria and crippling restrictions come this fall.

This madness must come to an end.

Recent PFE News

Maison Luxe Reports Best Ever Annual Revenues of Approximately $ 17.6 mil. for 2022 as Compared to Approximately $ 5.2 mil. for 2021, an Increase of Over 300% and Poised for Rapid Expansion in 2023 MASN Jun 30, 2022 9:58 AM

Global Fiber Technologies Secures Second Round of Inventory Financing GFTX Jun 30, 2022 9:41 AM

Sugarmade Announces Fully Executed LOI Toward Minority Stake Acquisition of Turnkey Cannabis Cultivation Property SGMD Jun 30, 2022 8:30 AM

HPIL(HPIL) Updates Shareholders HPIL Jun 30, 2022 8:30 AM

Emerging Markets Report: Cheaper. Simpler. More efficient. Ready to scale. SPYR Jun 29, 2022 11:41 AM

Oncology Pharma Conducting All The Preparations to Take Steps to Forward The Development Process of Nanoemulsion Drug Delivery System ONPH Jun 29, 2022 9:23 AM

Infobird Co., Ltd Provides Digital and Intelligent Customer Engagement Solution to Enhance Patient Vaccination Notification Services for a Top-10 Global Pharmaceutical Company's Subsidiary IFBD Jun 29, 2022 8:34 AM

Goldshore Resources Drills 78.35m at 1.17 g/t Au  and delineates higher grade lenses within Moss lake Deposit GSHRF Jun 29, 2022 8:33 AM

PSYC Provides Encouraging Update on its Investment in The Conscious Fund PSYC Jun 29, 2022 8:30 AM

Health Advance Inc. (OTC: HADV): Embrace their CBD Innovation Before Everyone Else Does! HADV Jun 29, 2022 8:00 AM

Resgreen Group Announces LilBuddy ™ Pilot Testing of Payload Capacity Exceeding Original Expectations RGGI Jun 29, 2022 6:00 AM

IGEN's CEO provides mid-year progress update for 2022 IGEN Jun 29, 2022 6:00 AM

Splash Beverage Group to Distribute TapouT through Save-A-Lot Grocery Stores in 32 States. SBEV Jun 28, 2022 8:23 AM

RYU Apparel Inc. (TSXV: RYU) (OTCQB: RYPPF) Announces Company Achievements and Roadmap For Shareholders with growth in Operations, Rollup Acquisition Strategy, and Disruptive Technology Opportunities RYPPF Jun 27, 2022 11:48 AM

Dalrada Energy Services Announces Partnership with Banyan Infrastructure to Improve ESG Banking Transparency DFCO Jun 27, 2022 9:35 AM

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y